What is compounded semaglutide and how long before it works?

9 minute read

By: Hadley Mendelsohn|Last updated: May 27, 2026|Medically reviewed by: Dr. Judith Barreiro
Middle aged Black woman in workout clothing, her hair in braids, smiling with her hand resting on her head in front of a foliage covered wall. header

Summary

Hormonal shifts during perimenopause and menopause can make weight gain—especially around the abdomen—more common and harder to reverse. GLP‑1 medications such as semaglutide help regulate appetite, slow digestion, and support metabolic health, which may assist with weight management when lifestyle strategies alone are not enough. Compounded versions prepared by specialized pharmacies can offer personalized dosing when branded medications are difficult to access. Appetite changes may appear within the first few weeks of treatment, while measurable weight loss usually develops gradually over several months.

Why Weight Gain Becomes More Common During Menopause

We’re all familiar with the saying, “the only constant in life is change,” and that may be especially true for women during midlife. One common shift? Weight gain, changes in body shape, and new metabolic challenges. In fact, up to 70 percent of women gain weight during the menopause transition, often averaging an extra one to one and a half pounds per year.

Much of this is related to declining estrogen, a hormone involved in many different body systems. It can influence weight in a few ways, including:

  • How the body stores fat, which can lead to more weight accumulating around the midsection

  • Blood sugar regulation, which may become less efficient

  • Sleep issues, which are often caused by hot flashes, night sweats, and other menopause symptoms, can then lead to daytime fatigue and mess with other hormones

  • Increasing appetite and cravings 

Considered together, these changes can make weight management feel harder than it used to. That means lifestyle changes alone may not be enough for everyone. For many women, the most effective approach combines healthy habits, treatment for menopause symptoms, and, in some cases, medications such as GLP-1s.

“Many women feel understandably frustrated when they do the same things that always worked in the past,  but suddenly their bodies respond differently or not at all. This happens frequently during menopause and medications like semaglutide can provide the additional support when lifestyle changes alone are just not enough.” - Dr. Judith Barreiro

Ahead, we’ll explore one of those options, compounded semaglutide, and other strategies that may help support weight management during menopause.

What Compounded Semaglutide Is (and How It Differs From Branded GLP‑1 Medications)

Semaglutide belongs to a class of medications called GLP-1 receptor agonists. In simple terms, these medications mimic a natural gut hormone that helps regulate appetite and blood sugar. The result is that you may feel fuller sooner, stay satisfied longer, and experience fewer cravings.

Both branded and compounded GLP-1 medications require a prescription and ongoing medical supervision. They also. contain similar active ingredients, but they differ in how they’re manufactured and regulated.

Specifically, branded GLP-1 medications are mass-produced by pharmaceutical manufacturers and reviewed through the FDA approval process for certain indications, doses, and formulations. Examples include:

  • Wegovy® and Ozempic® (semaglutide)

  • Victoza® and Saxenda® (liraglutide) 

  • Zepbound® and Mounjaro® (tirzepatide)

These medications are made using standardized, FDA-approved formulations and have been studied extensively in large clinical trials to establish their safety, effectiveness, and common side effects.

So, where does compounded semaglutide for menopause weight gain enter the picture? Compounded GLP-1 medications can expand access in a range of situations, such as during drug shortages, when a commercially available dose isn’t appropriate, or if someone is sensitive to an ingredient in the branded, standard version.

NEWCompounded Semaglutide

Compounded Semaglutide

Starting at $70

Compounded medications may also be a practical option when insurance coverage is limited or out-of-pocket costs are making it harder to get treatment, both of which are common barriers. And because compounded medications can be tailored to individual needs, they can offer added flexibility when a more personalized approach makes sense.

Also, unlike branded medications, compounded meds aren’t reviewed and approved by the FDA as finished products. Instead, they’re prepared by licensed pharmacies that are subject to federal and state oversight.

Alloy partners with FDA-regulated compounding pharmacies to help ensure consistent quality, appropriate dosing, and clinician-guided care

How GLP‑1 Medications Like Semaglutide Affect Appetite and Metabolism

GLP-1 is a hormone your gut naturally releases after you eat. It helps regulate several key processes involved in appetite, digestion, and blood sugar control. Basically, after a meal, GLP-1 signals the pancreas to release insulin, slows how quickly food leaves the stomach, and communicates with the brain to increase feelings of fullness.

Medications like semaglutide mimic this hormone, essentially amplifying the body’s own satiety signals. Because of this, they can:

  • Reduce hunger and cravings

  • Quiet “food noise,” or persistent thoughts about eating

  • Help you feel satisfied with smaller portions

  • Improve blood sugar control

Over time, these effects can make it easier to eat less without feeling deprived, which can support meaningful and sustainable weight loss.

And now, putting the spotlight back on weight gain during midlife: This can all be particularly helpful during menopause, when hormonal changes may increase appetite, disrupt blood sugar regulation, and shift fat storage toward the midsection. 

Research suggests that even low doses of GLP-1s can help with weight changes during this era—and they’re especially effective when combined with healthy eating habits, strength training, and adequate sleep.

How Long It Usually Takes to Notice Results With Semaglutide

As with all medications, how long it takes to see results with semaglutide really does vary from person to person. How quickly it works depends on factors like your dose, how consistently you take the medication, and whether it’s paired with supportive lifestyle changes such as nutrition, exercise, and sleep.

Still, semaglutide often begins affecting appetite and fullness within the first few weeks. The half-life is three days, so it technically starts working in your body pretty fast. Some people notice early changes in hunger, cravings, or weight within 1 to 4 weeks.

More noticeable weight loss typically occurs over the next 1 to 3 months as the dose is gradually increased toward a maintenance level.

Clinical trials show that weight loss tends to build steadily over time. In one study of 2.4 mg of once-weekly semaglutide injections, participants lost about two percent of their body weight after 4 weeks and nearly eight percent by around 16 weeks. By the end of the 68-week trial, average weight loss was approximately 15 percent of body weight—about 34 pounds for someone starting at 230 pounds.

Long story short, semaglutide isn’t a singular, overnight fix. But when used consistently and paired with healthy habits, it can lead to meaningful, sustained weight loss over time.

“One of the most important things we talk about with patients is setting realistic expectations. The goal is steady, sustainable progress. For most patients it’s a marathon not a sprint” - Dr. Judith Barreiro

What Side Effects and Safety Questions to Know About

Semaglutide is generally considered safe when prescribed appropriately and monitored by a healthcare provider.

Like other GLP-1 medications, the most common side effects are gastrointestinal. They can include: 

  • Nausea

  • Bloating

  • Constipation

  • Diarrhea

  • Vomiting

The good news is that these symptoms are often temporary. They tend to be most noticeable during the first few weeks of treatment or after a dose increase, then improve as the body adjusts. To help reduce the likelihood of these side effects, healthcare providers typically use a gradual dose-escalation schedule (which is a fancy way of saying that they slowly increase the dose over time). 

If you’re using an injectable form of semaglutide, mild redness or irritation at the injection site can also occur.

It’s also important to maintain adequate protein intake and continue strength training during treatment, especially as estrogen decline impacts bone health during and after menopause. This can help preserve muscle mass while supporting healthy, sustainable weight loss.

Certain medical conditions, medications, and personal risk factors may affect whether semaglutide is appropriate for you. That’s why it’s important to review your full health history with a qualified healthcare provider before starting treatment.

Can Semaglutide Be Used With Menopause Hormone Therapy?

Yes, in many cases, both semaglutide and hormone replacement therapy (HRT) can be used together in a holistic treatment plan. 

HRT works by replacing some of the estrogen that declines during perimenopause and menopause. This can help relieve symptoms like hot flashes, sleep disruption, and mood changes. And when you’re sleeping better and feeling more like yourself, it may become easier to focus on the habits that support weight management, like eating well, exercising regularly, and getting enough rest.

Estrogen therapy may also help limit the increase in abdominal fat that often accumulates during menopause. But even though it may support general health and metabolism on top of those other menopause symptoms, HRT isn’t considered a straight-up weight loss treatment. 

That’s where GLP-1 medications like semaglutide may enter the treatment plan to offer additional support.

Semaglutide works directly on appetite regulation, blood sugar, and satiety. In other words, HRT helps address the hormonal changes of menopause, while semaglutide targets some of the metabolic shifts that can make weight loss feel harder than it used to.

Used together, HRT and GLP-1 treatments may complement each other. Early research suggests that addressing both hormonal and metabolic factors can lead to better weight and health outcomes than focusing on either one alone.

At Alloy, eligible patients may be prescribed both HRT and GLP-1 medications. A menopause-trained clinician can help determine whether one, the other, or a combination of both makes sense for your goals and medical history.

Questions to Ask Before Starting Compounded Semaglutide

If you’re curious to learn more about compounded semaglutide and think you might be a good fit for treatment, setting up a conversation with a qualified healthcare provider is a great place to start. Ideally, that provider should understand not just weight management, but the hormonal changes that can make menopause-related weight gain feel especially frustrating.

Here are a few helpful questions and talking points to keep handy during your conversation:

  • Am I a good candidate based on my BMI, medical history, and current symptoms?

  • How does the dosing schedule work, and how will my dose be adjusted over time?

  • How will my progress be monitored?

  • When should I expect to notice changes in appetite and weight?

  • What side effects are most common, and how can they be managed?

  • What should I do if I hit a weight loss plateau or don’t see results right away?

  • What nutrition, protein, and strength-training habits will help me get the best results? 

If you end up getting prescribed compounded semaglutide, it’s reasonable to ask where the medication is sourced and manufactured. 

Branded GLP-1 medications are FDA-approved and manufactured at scale under strict federal oversight. Compounded GLP-1 medications aren’t individually FDA-approved, but they are prepared by licensed compounding pharmacies that operate under federal and state regulations.

At Alloy, compounded medications are sourced from FDA-regulated compounding pharmacies with rigorous quality standards, and treatment is overseen by menopause-trained clinicians who can help determine whether this approach is appropriate for you.


Frequently Asked Questions

Why is weight management more difficult during the menopause transition?

Weight gain during menopause is a common challenge, affecting up to 70 percent of women due to declining estrogen levels. This hormonal shift influences several bodily systems, often leading to more fat accumulation around the midsection, less efficient blood sugar regulation, and increased appetite or cravings. Additionally, menopause symptoms like hot flashes and night sweats can disrupt sleep, causing daytime fatigue that further interferes with metabolic health and makes traditional lifestyle changes feel less effective than they were in the past.

How do GLP-1 medications like semaglutide help address hormonal weight changes?

Semaglutide belongs to a class of medications called GLP-1 receptor agonists, which mimic a natural gut hormone released after eating. This hormone signals the brain to increase feelings of fullness, slows the speed at which food leaves the stomach, and helps the pancreas release insulin. By amplifying these satiety signals, semaglutide can "quiet" persistent thoughts about food and reduce cravings, making it easier to maintain a calorie deficit without feeling deprived. This is particularly helpful during menopause when hormonal shifts naturally disrupt appetite and blood sugar control.

Can semaglutide be used at the same time as Hormone Replacement Therapy?

Yes, in many cases, semaglutide and hormone replacement therapy (HRT) can be used together as part of a holistic treatment plan. While HRT works to replace declining estrogen and relieve symptoms like hot flashes and poor sleep, it is not a direct weight-loss treatment. Semaglutide complements HRT by targeting metabolic shifts and appetite regulation. Research suggests that addressing both the hormonal symptoms of menopause and the metabolic challenges of weight gain simultaneously may lead to better overall health outcomes than using either treatment alone.

Related Content

  1. https://www.myalloy.com/solutions/compounded-liraglutide

  2. https://www.myalloy.com/solutions/wegovy

  3. https://myalloy.zendesk.com/hc/en-us/articles/39471023349523-Can-I-take-GLP-1-medication-with-Menopausal-Hormone-Therapy-MHT

  4. https://www.myalloy.com/blog/why-glp-1s-and-mht-are-a-beneficial-combination

  5. https://www.myalloy.com/blog/how-long-does-it-take-for-semaglutide-to-work

  6. https://www.myalloy.com/blog/how-long-until-compounded-liraglutide-works

  7. https://www.myalloy.com/blog/what-is-compounded-liraglutide

  8. https://www.myalloy.com/solutions

  9. https://www.youtube.com/watch?v=voedsMd4Zsc

  10. https://www.youtube.com/watch?v=s-vJkYKXhs0

  11. https://myalloy.zendesk.com/hc/en-us/articles/30013148243219-Does-Alloy-offer-Progesterone

Citations

  1. Hana Mikdachi, Rebecca Dunsmoor-Su. GLP-1 receptor agonists for weight loss for perimenopausal and postmenopausal women: current evidence. Curr Opin Obstet Gynecol 2025;37(2):97-101. PMID:39970049.

    View source
  2. Maria D Hurtado, Elif Tama, Sima Fansa, Wissam Ghusn, Diego Anazco, Andres Acosta, et al.. Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use. Menopause 2024;31(4):266-274. PMID:38446869.

    View source
  3. Joana Nicolau, Jorge Blanco-Anesto, Aina Bonet, Juan José Félix-Jaume, Apolonia Gil-Palmer. Effectiveness of Low Doses of Semaglutide on Weight Loss and Body Composition Among Women in Their Menopause. Metab Syndr Relat Disord 2025;23(1):70-76. PMID:39761057.

    View source
  4. Santiago Palacios, Peter Chedraui, Rafael Sanchez-Borrego, Pluvio Coronado, Tommaso Simoncini, Katrin Schauding, et al.. Management of obesity in menopause. Climacteric 2024;27(4):357-363. PMID:39016333.

    View source
  5. Nicole A Graczyk, Julia Bisschops. Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) for Obesity and Symptoms in Menopause: A Review. Cureus 2026;18(1):e101693. PMID:41704988.

    View source
  6. Maneeha Naveed, Cecilie Perez, Ehtasham Ahmad, Laura Russell, Zoe Lees, Catriona Maybury. GLP-1 medication and weight loss: Barriers and motivators among 1659 participants managed in a virtual setting. Diabetes Obes Metab 2025;27(7):3780-3788. PMID:40259493.

    View source
  7. Adrian Holliday, Katy Horner, Kelsie O Johnson, et al. Appetite-related Gut Hormone Responses to Feeding Across the Life Course. J Endocr Soc 2025;9(2):bvae223. PMID:39777204.

    View source

Share this post

Subscribe

Go ahead, you deserve to

feel fantastic

Stay connected

Follow us